Recent Articles

September 4, 2014 10:36 am
Matthew Weinberg, CEO, The Weinberg Group
Outsourcing is an old concept in the healthcare industry that has recently been applied to a new area: regulatory affairs. Traditionally conducted in-house, regulatory affairs is extremely critical to a product’s success. For certain companies, this entire function can and should be outsourced in its entirety, not just for discrete projects.
September 3, 2014 10:15 am
Cynthia Fox, Science Editor
ZMapp, the experimental drug that may have already have saved a few patients in Africa, is the most effective anti-Ebola therapy yet, according to a recent Nature paper on rhesus macaques monkeys. Read more...           
August 29, 2014 8:30 am
Steve Scribner, Principal Consultant – Life Sciences, EMC Information Intelligence Group
Getting a new drug from the laboratory to the pharmacy takes years of testing, applications and information sharing. One way to shorten the drug development life cycle is to optimize content management. Read more...          
August 28, 2014 9:30 am
Maxim Mikheev, M.D., Ph.D., Co-Founder and Chief Technical Officer at BioDatomics
As technological improvements have changed the way we study the genome, the amount of data associated with a single DNA sample has increased exponentially. Surprisingly, throughout this evolution the hardware and software infrastructure supporting bioanalytics has barely changed. Read more...
August 27, 2014 9:58 am
Seth Lederman, M.D., CEO, Tonix Pharmaceuticals
Drugs can be discovered and developed in two very different ways: at an evolutionary pace and at a revolutionary pace. The “first revolution” in biological psychiatry took place in the 1950s, and now, in the 21st century, a “second revolution” of drug development and discovery is taking place, driven by repurposing.
Subscribe to Drug Discovery & Development